Notice2026-10012
Advisory Committee on Immunization Practices (ACIP); Notice of Charter Re-Establishment
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 19, 2026
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
Pursuant to the Public Health Service Act, as amended, and the Federal Advisory Committee Act, as amended, the Centers for Disease Control and Prevention (CDC) announces the re-establishment of the Advisory Committee on Immunization Practices (ACIP). A notice of committee charter renewal for the ACIP, which was published in the Federal Register on April 6, 2026, is hereby withdrawn. In this document, the CDC also announces the determination that the re- establishment of the ACIP is necessary and in the public interest in connection with the Department of Health and Human Services' (HHS) performance of its duties.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 96 (Tuesday, May 19, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 96 (Tuesday, May 19, 2026)]
[Notices]
[Pages 29139-29140]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-10012]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP); Notice of
Charter Re-Establishment
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Committee management; Withdrawal of notice of committee charter
renewal; Notice of committee charter re-establishment.
-----------------------------------------------------------------------
SUMMARY: Pursuant to the Public Health Service Act, as amended, and the
Federal Advisory Committee Act, as amended, the Centers for Disease
Control and Prevention (CDC) announces the re-establishment of the
Advisory Committee on Immunization Practices (ACIP). A notice of
committee charter renewal for the ACIP, which was published in the
Federal Register on April 6, 2026, is hereby withdrawn. In this
document, the CDC also announces the determination that the re-
establishment of the ACIP is necessary and in the public interest in
connection with the Department of Health and Human Services' (HHS)
performance of its duties.
FOR FURTHER INFORMATION CONTACT: ACIP Secretariat, Advisory Committee
on Immunization Practices, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H21-12, Atlanta, Georgia 30329-4027.
Email: <a href="/cdn-cgi/l/email-protection#9adbd9d3cadaf9fef9b4fdf5ec"><span class="__cf_email__" data-cfemail="c08183899080a3a4a3eea7afb6">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In accordance with the Federal Advisory
Committee Act, as amended (5 U.S.C. 1001 et seq.), CDC is providing
notice of the re-establishment of the charter of the ACIP, CDC, HHS.
This charter is being re-established for a two-year period.
Withdrawal of previously published notice: The notice of charter
renewal published on April 6, 2026 (91 FR 17279) is hereby withdrawn
due to an administrative error in meeting the revised public
notification timing requirements under the revised Federal Advisory
Committee Act regulations, as amended in December 2025 (41 CFR 102-
3.65). As a result, the charter lapsed and the committee must be re-
established.
Public Interest Determination
Pursuant to 41 CFR 102-3.60(a), to establish, renew, reestablish,
or merge a discretionary (agency discretion) advisory committee, an
agency must first consult with the General Services Administration's
Committee Management Secretariat (the Secretariat) and, as part of the
consultation, provide a written public interest determination approved
by the head of the agency to the Secretariat with a copy to the Office
of Management and Budget. In addition, pursuant to 41 CFR 102-3.35, an
agency shall follow the same consultation process and document in
writing the same determination of need before creating a subcommittee
under a discretionary committee that is not made up entirely of members
of a parent advisory committee.
Information on the following factors for the committee is provided
to the Secretariat to demonstrate that re-establishing the committee is
in the public interest:
1. Annual budget: Estimated annual costs for operating the
Committee, including (i) Federal personnel (3) and other Federal
internal costs are $1,080,340; (ii) proposed compensation and travel
expense payments for up to 19 members is $42,750; and (iii)
reimbursable costs are $83,106.
2. If applicable, the total dollar value of grants expected to be
recommended during the fiscal year, $0.
3. Criteria for selecting members to ensure the committee has the
necessary expertise and fairly balanced membership: To identify
nominees capable of maintaining fairly balanced membership who
collectively represent a balanced range of scientific, clinical, and
public health expertise relevant to the ACIP's mission to advise and
provide recommendations to the CDC Director on vaccines and
immunizations, CDC conducts broad outreach using multiple channels.
Outreach is designed to reach interested parties, as appropriate to the
Committee's function, and stakeholders likely to possess the expertise
and perspectives identified above. Outreach priorities may change as
vacancies arise and as the Committee's agenda evolves.
In conducting outreach and screening candidates, the Designated
Federal Officer (DFO) as well as the ACIP Secretariat assess current
and anticipated Committee needs based on the charter, the active work
plan, upcoming vacancies, and any identified gaps in expertise or
perspectives. Consideration is given to geographic diversity, diversity
of relevant work settings, and the need for balanced expertise across
clinical medicine, immunization practice, immunology, infectious
diseases, epidemiology, biostatistics and data analysis, vaccine safety
and effectiveness evaluation, health economics, public health
implementation, health systems and
[[Page 29140]]
program operations, special populations, and consumer and community
perspectives.
The DFO, in collaboration with the ACIP Secretariat, solicits
candidate names through multiple channels, which may include:
<bullet> Publication of nomination notices in the Federal Register;
<bullet> Information and application procedures on the ACIP website
at <a href="https://www.cdc.gov/acip/apply-for-membership/index.html">https://www.cdc.gov/acip/apply-for-membership/index.html</a>, including
a continuous nomination process throughout the year;
<bullet> Announcements and application information at ACIP meetings
and webcasts;
<bullet> Outreach to professional associations, public health
organizations, academic institutions, state, local, Tribal, and
territorial partners, health systems, and consumer or community
organizations, as appropriate to address identified expertise gaps or
community perspectives;
<bullet> Recommendations from current or former Committee members,
CDC subject matter experts, and other knowledgeable sources, as
appropriate; and
<bullet> Targeted outreach, when needed, to identify nominees with
expertise relevant to special populations, implementation in diverse
settings, or other emerging needs reflected in the Committee's work.
Members, including the Chair and Vice Chair, shall be selected by
the HHS Secretary and shall be invited to serve for overlapping terms
of up to four years, except that any member appointed to fill a vacancy
for an unexpired term shall be appointed for the remainder of that
term. A member may serve 180 days after the expiration of that member's
term if a successor has not taken office.
4. List of all other Federal advisory committees of the agency:
<bullet> Advisory Board on Radiation and Worker Health
<bullet> Advisory Committee for the Elimination of Tuberculosis
<bullet> Advisory Committee on Breast Cancer in Young Women
<bullet> Advisory Committee to the Director, CDC
<bullet> Board of Scientific Counselors, National Center for Injury
Prevention and Control
<bullet> Lead Exposure and Prevention Advisory Committee
<bullet> Mine Safety and Health Research Advisory Committee
<bullet> National Committee on Vital and Health Statistics
<bullet> World Trade Center Health Program Scientific/Technical
Advisory Committee
5. Justification that the information or advice provided by the
Federal advisory committee or subcommittee is not available from
another Federal advisory committee, another Federal Government source,
or any other more cost-effective and less burdensome source: The ACIP
has been given statutory roles under subsections 1928(c)(2)(B)(i) and
1928(e) of the Social Security Act (42 U.S.C. 1396s(c)(2)(B)(i) and
1396s(e)) and subsection 2713(a)(2) of the Public Health Service Act
(42 U.S.C. 300gg-13(a)(2)). In accordance with Section 1928 of the
Social Security Act, the ACIP shall establish and periodically review
and, as appropriate, revise the list of vaccines for administration to
children and adolescents eligible to receive vaccines through the
Vaccines for Children (VFC) Program, along with schedules regarding the
appropriate dose and dosing interval, and contraindications to
administration of the pediatric vaccines. The Secretary, and as
delegated the CDC Director, shall use the list established by the ACIP
for the purpose of the purchase, delivery, and administration of
pediatric vaccines in the VFC Program. Further, under provisions of the
Affordable Care Act (Section 2713 of the Public Health Service Act, as
amended), immunization recommendations of the Committee that have been
adopted by the Director of the CDC must be covered by applicable health
plans. Therefore, the advice provided by the ACIP is not available from
another Federal advisory committee or Federal Government source, or any
other more cost-effective and less burdensome source.
6. Explanation of why the committee/subcommittee is essential to
the conduct of agency business: The Secretary, HHS, and by delegation
the Director, CDC, are authorized under Section 311 and Section 317 of
the Public Health Service Act, [42 U.S.C. 243 and 42 U.S.C. 247b], as
amended, to assist states and their political subdivisions to assist in
the prevention and control of communicable diseases and to support
related public health activities. The ACIP provides advice and
recommendations to the CDC Director on the use of vaccines and
immunization program strategies to inform clinical practice and public
health action. The Committee convenes scientific and medical experts to
evaluate the best available evidence regarding vaccine safety,
efficacy, effectiveness, and implementation. ACIP shall provide advice
and guidance regarding the use of vaccines and related immunobiologic
agents for the control of vaccine-preventable diseases in the United
States, including identifying areas where additional data or evaluation
would inform future recommendations. Recommendations made by ACIP are
reviewed by the CDC Director and, if adopted, become official CDC and
HHS recommendations and may be published in the Morbidity and Mortality
Weekly Report (MMWR).
In conclusion, this public interest determination documents that
re-establishing the committee is in the public interest, essential to
the conduct of agency business, and that the information to be obtained
is not already available through another advisory committee or source
within the Federal Government.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the CDC and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2026-10012 Filed 5-18-26; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 19, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.